Discovery, Chroma Collaborate for Lead Identification on Multiple Targets

Discovery Partners International (DPI) and Chroma Therapeutics have entered into a collaboration focused on the discovery of potential new lead compounds against several selected targets.

Chroma will provide the targets, and DPI will use its comprehensive compound collection and its proprietary discovery processes and data management tools to identify potential lead compounds or potential lead series. Financial terms of the collaboration were not disclosed.